Bactericidal properties of urine for neisseria gonorrhoeae

Sexually Transmitted Diseases

Volumn 14, Issue 4, 1987, Pages 221-226

  Noble, Robert C ^a   Parekh, Manhar C ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDE;

HUMAN; NEISSERIA GONORRHOEAE; NONHUMAN; URINE;

DIALYSIS; FATTY ACIDS; FLUORIDES; HUMAN; HYDROGEN-ION CONCENTRATION; MALE; MURAMIDASE; NEISSERIA GONORRHOEAE; PRONASE; URINE; ZINC;

EID: 0023520122     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/00007435-198710000-00009     Document Type: Article

References (30)

1. Hooper RR, Reynolds GH, Jones OG, et al. Cohort study of venereal disease. I. The risk of gonorrhea transmission from infected women to men. Am J Epidemiol 1978; 108:136-44.
2. McCutchan JA, Wunderlich A, Braude AI. Role of urinary solutes in natural immunity to gonorrhea. Infect Immun 1977; 15:149-55.
3. Houser MT. Improved turbidimetric assay for lysozyme in urine. Clin Chem 1983; 29:1488-93.
4. Catlin BW. Nutritional profiles of Neisseria gonorrhoeae, Neis-seria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing. J Infect Dis 1973; 128:178-94.
5. Catlin BW. Characteristics and auxotyping of Neisseria gonorrhoeae. In: Bergen T, Norris JR, eds. Methods in microbiology. Vol. 10. New York: Academic Press, 1978; 345-80.
6. Hendry AT, Stewart IO. Auxanographic grouping and typing of Neisseria gonorrhoeae. Can J Microbiol 1979; 25:512-21.
7. White LA, Kellogg DS. Neisseria gonorrhoeae identification in direct smears by a fluorescent antibody-counterstain method. Appl Microbiol 1965; 13:171-4.
8. Swanson J. Studies on gonococcus infection. XII. Colony, color, and opacity variants of gonococci. Infect Immun 1978; 19:320-31.
9. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Canad J Biochem Physiol 1959; 37:911-17.
10. Miller RD, Brown KE, Morse SA. Inhibitory action of fatty acids on the growth of Neisseria gonorrhoeae. Infect Immun 1977; 17:303-12.
11. Noble RC, Miller BR. Auxotypes and antimicrobial susceptibilities of Neisseria gonorrhoeae in black and white patients. Br J Vener Dis 1980; 56:26-30.
12. Noble RC, Parekh MC. Association of auxotypes of Neisseria gonorrhoeae and susceptibility to penicillin G, spectinomycin, tetracycline, cefaclor, cefoxitin, and moxalactam. Sex Transm Dis 1983; 10:18-23.
13. Noble RC, Parekh MC. Changes in the prevalence of auxotypes of Neisseria gonorrhoeae among black and white patients attending a clinic for sexually transmitted diseases. Sex Transm Dis 1983; 10:14-7.
14. Stewart IO, Hendry AT. Association between the auxogroup of Neisseria gonorrhoeae and the minimal inhibitory concentration of penicillin. Sex Transm Dis 1979; 6:247-52.
15. Hemmingsen L, Skaarup P. The 24-hour excretion of plasma proteins in the urine of apparently healthy subjects. Scand J Clin Lab Invest 1975; 35:347-53.
16. Schumacher GB. Lysozyme in human genital secretions, In: Os-serman EF, Canfield RE, Beychok S, eds. Lysozyme. New York: Academic Press, 1974:427-47.
17. Morse SA, Lysko PG, McFarland L, et al. Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun 1982; 37:432-8.
18. Chalmers RA, Bickle S, Watts RWE. A method for the determination of volatile organic acids in aqueous solutions and urine, and the results obtained in propionic acidaemia, beta-methyl-crotonylglycinuria and methylmalonic aciduria. Clin Chim Acta 1974; 52:31-41.
19. Hagenfeldt L. Renal excretion of free fatty acids. Clin Chim Acta 1971; 32:471-4.
20. Przyrembel H, Wendel U, Becker K, et al. Glutaric aciduria type II: Report on a previously undescribed metabolic disorder. Clin Chim Acta 1976; 66:227-39.
21. Triebig G, Schaller K-H. A simple and reliable enzymatic assay for the determination of formic acid in urine. Clin Chim Acta 1980; 108:355-60.
22. Williams DL, Spray GH. Urinary excretion of short-chain fatty acids in latent pernicious anaemia and related conditions. Br J Haematol 1974; 26:185-91.
23. Fair WR, Heston WDW. The relationship of bacterial prostatitis and zinc. In: Brewer GJ, Prasad AS, eds. Zinc metabolism: current aspects in health and disease. New York: Alan R. Liss, Inc., 1977:129-40.
24. Novick RP, Roth C. Plasmid-linked resistance to inorganic salts in Staphylococcus aurens. J Bacteriol 1968; 95:1335-42.
25. Greenberg SB, Harris D, Giles P, Martin RR, Wallace RJ, Jr. Inhibition of Chlamydia trachomatis growth in McCoy, HeLa, and human prostate cells by zinc. Antimicrob Agents Che-mother 1985; 27:953-7.
26. Helwig HL, Hoffer EM, Thielen WC, Alcocer AE, Hotelling DR, Rogers WH. Modified zinc analysis method and serum and urinary zinc levels in control subjects. Am J Clin Pathol 1966; 45:160-5.
27. LaForce FM, Boose DS. Effect of zinc and phosphate on an antibacterial peptide isolated from lung lavage. Infect Immun 1984; 45:692-6.
28. Schlievert P, Johnson W, Galask RP. Isolation of a low-molecular-weight antibacterial system from human amniotic fluid. Infect Immun 1976; 14:1156-66.
29. Kashket S, Kashket ER. Dissipation of the proton motive force in oral streptococci by fluoride. Infect Immun 1985; 48:19-22.
30. Spencer H, Lewin I, Wistrowski E, Samachson J. Fluoride metabolism in man. Am J Med 1970; 49:807-13.